The FDA s approval of a chikungunya vaccine brings hope to regions facing the highest risk of the mosquito-borne virus that has affected over 110 countries.
As a new generation of weight-loss medications has created additional options to treat obesity, insurance coverage barriers limit broad accessibility of these medications. In response, physicians and medical students voted to adopt policy for the American Medical Association (AMA) supporting health insurance coverage parity for evidence-based treatment of obesity, including FDA-approved medications without exclusions or additional carve-outs. The AMA regards obesity as a disease that pose.